Patents by Inventor Haruo Tsuchiya
Haruo Tsuchiya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9370565Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: GrantFiled: October 31, 2013Date of Patent: June 21, 2016Assignee: The Johns Hopkins UniversityInventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20140099307Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: October 31, 2013Publication date: April 10, 2014Applicant: The Johns Hopkins UniversityInventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20120065374Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: September 23, 2011Publication date: March 15, 2012Inventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20120065385Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefore and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: September 23, 2011Publication date: March 15, 2012Inventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Patent number: 8053558Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: GrantFiled: October 31, 2007Date of Patent: November 8, 2011Assignee: The Johns Hopkins UniversityInventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Patent number: 8053414Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: GrantFiled: October 31, 2007Date of Patent: November 8, 2011Assignee: The Johns Hopkins UniversityInventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Patent number: 7560540Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: GrantFiled: February 24, 2006Date of Patent: July 14, 2009Assignee: The Johns Hopkins UniversityInventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20080241175Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: October 31, 2007Publication date: October 2, 2008Inventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20080226662Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: October 31, 2007Publication date: September 18, 2008Inventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20060292593Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: February 24, 2006Publication date: December 28, 2006Applicant: The Johns Hopkins UniversityInventors: Drew Pardoll, Haruo Tsuchiya, Kevin Gorski, Su-Yi Tseng
-
Patent number: 7030219Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: GrantFiled: February 28, 2001Date of Patent: April 18, 2006Assignee: Johns Hopkins UniversityInventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Publication number: 20020091246Abstract: A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.Type: ApplicationFiled: February 28, 2001Publication date: July 11, 2002Inventors: Drew M. Pardoll, Haruo Tsuchiya, Kevin S. Gorski, Su-Yi Tseng
-
Patent number: 4224252Abstract: Disclosed are improved procedures for preparing pinacolone from compounds of general formula (I) ##STR1## wherein, either adjacent two of A, B, C and D form a single bond between them and the remaining two are hydrogen atoms, or both A and D are hydrogen atoms and one of B and C is a hydrogen atom and the other represents OH, Cl, Br, HSO.sub.4, H.sub.2 PO.sub.4 or ClO.sub.4, anda new procedure which enables preparing pinacolone from a compound of general formula (II) ##STR2## wherein, both W and Y are each hydrogen atoms and X and Z are the same or different and each represents OH, Cl, Br, HSO.sub.4, H.sub.2 PO.sub.4, ClO.sub.4 or RCOO wherein R is a hydrogen atom or an alkyl group of 1 to 3 carbon atoms, or one of W and Y is a hydrogen atom and the other forms a single bond together with X, and Z represents OH, Cl, Br, HSO.sub.4 H.sub.2 PO.sub.4, ClO.sub.4 or RCOO where R is defined as above.Type: GrantFiled: May 15, 1979Date of Patent: September 23, 1980Assignee: Kuraray Co., Ltd.Inventors: Sunao Kyo, Haruo Tsuchiya, Hidetsugu Tanaka